Hytham Abu Aagla/ LinkedIn
Oct 26, 2026, 12:38
Hytham Abu Aagla: Daratumumab and Transfusion Compatibility
Hytham Abu Aagla, Haematolgy Registrar at Cork University Hospital, shared post on LinkedIn:
“Daratumumab and Blood Transfusion: What Every Clinician Should Know
Daratumumab is widely used to treat multiple myeloma, but its interference with pre-transfusion compatibility testing can create significant challenges for blood banks.
Understanding this interference and how to manage it is essential to ensuring safe and timely blood transfusions.”
Stay updated with Hemostasis Today.
-
Oct 26, 2026, 10:17Pankaj K.: Genetic Hemolytic Anemias Common Types, Symptoms and Long-Term Management
-
Oct 26, 2026, 10:09Christopher Robinson: Anemia and Postpartum Transfusion Rates at Different Blood Loss Thresholds After Vaginal Delivery
-
Oct 26, 2026, 09:54Hussnain Javaid: IV Iron During Active Bacterial Infection Reassessing the Risks and Benefits
-
Oct 26, 2026, 09:37Fathima Zulfa Mohamed Sattar: Systematic Investigation of Bleeding Disorders and Coagulation Abnormalities
-
Oct 26, 2026, 09:12Robert Major: GFAP as a Point-of-Care Biomarker in Intracerebral Hemorrhage
-
Oct 26, 2026, 08:55Abdulla A. Damluji: LATE-MT Reveals Benefits and Risks of Late Thrombectomy
-
Oct 26, 2026, 05:28Anirban Sen Gupta: Celebrating 20 Years of Research and Innovation
-
Oct 26, 2026, 05:13Shamee Shastry: ScholarGPS Recognises a Highly Ranked Blood Transfusion Scholar
-
Oct 26, 2026, 03:43Shazmah Shaikh: How Laser Atherectomy Helps Clear Blocked Arteries